+ 44 (0) 1295 660117

sales@gfcdiagnostics.com

New book

Smoking – what all healthcare professionals need to know by Dr. Graham F. Cope

Available from www.mkupdate.co.uk

References

SmokeScreen - Urine - Graham F. Cope

Cope GF

• Cope GF. Reliability of self reported smoking status by pregnant women for estimating smoking prevalence: a retrospective, cross sectional study. British Medical Journal 2009.

• Cope GF. Smoking status and pregnancy - utility of point of care cotinine test during pregnancy.  British Medical Journal 2009; 339 b5652  

• Cope GF, Battersby N. Smoking verification and the risk of myocardial infarction. Journal of Epidemiology and Community Health 2004; 58: 156.

• Cope GF, Nayyar P, Holder R. Feedback from a point of care test for nicotine intake to reduce smoking during pregnancy. Annals of Clinical Biochemistry 2003; 40: 674-679

• Cope GF, Nayyar P, Holder R. Measurement of nicotine intake in pregnant women – associations to changes in blood cell count. Nicotine Tobacco Res 2001; 3: 119-122.

• Cope G, Nayyar P, Wilkinson L, Holder R. A simple colorimetric test to quantify exposure to environmental tobacco smoke - an occupational health study. Ann Clin Biochem 2000; 37: 795-796.

• Cope GF. Cotinine levels in women who smoke during pregnancy. Am J Obstet Gynecol 1999: 180: 301. Am J Obstet Gynecol 1999; 180: 1310       

• Cope GF, Mather LV, Darcy Y, Afnan M. Smoking - good or bad for semen? Fertility and Sterility 1997; 68: 565.

• Cope G, Nayyar P, Holder R, Gibbons J, Bunce R. A simple near-patient test for nicotine and its metabolites in urine to assess smoking habit. Clin Chim Acta 1996; 256: 135-49.

INDEPENDENT

• Nicolau, Ioana; Tian, Lulu; Menzies, Dick; et al. Point-of-care urine tests for smoking status and isoniazid treatment monitoring in adult patients. PLOS One 2012; 7: Article No: e45913

• Spears M, Donnelly I, Jolly L, Brannigan M, Ito K, McSharry C, et al. Peripheral blood dendritic cell subtypes are significantly elevated in subjects with asthma. Clinical & Experimental Allergy 2011; 41: 665–672

• Jolly K, Lip GYH, Taylor RS, Raftery J, Mant J, Lane D, Greenfield, Stevens A. The Birmingham rehabilitation uptake maximisation study (BRUM): a randomised controlled trial comparing home-based with centre-based cardiac rehabilitation. Heart ; 95; 36-42

• Fazeli B, Arshadi H. A plan of group therapy for smoking cessation in patients suffering from buerger’s disease: a case series study in northeast Iran. Journal of Smoking Cessation, 2009; 4: 42–47

• Spears M, Donnelly I, Jolly L, Brannigan M, Ito K, McSharry C, et al. Bronchodilatory effect of the ppar-γ rosiglitazone in smokers with asthma. Clinical Pharmacology & Therapeutics

• Spears M, Donnelly I, Jolly L, Brannigan M, Ito K, McSharry C, et al Effect of low-dose theophylline plus Beclometasone on lung function in smokers with asthma: a pilot study. Eur Respir J 2009; 33: 1010–1017

• Jolly K, Taylor R, Lip GYH, Greenfield S, Raftery J, Mant J, Lane D, Jones M, Lee KW, Stevens A. The Birmingham Rehabilitation Uptake Maximisation Study (BRUM). Homebased compared with hospital-based cardiac rehabilitation in a multi-ethnic population: cost-effectiveness and patient adherence. Health Technology Assessment ; 11: Art No. 35

• Payne CE, Southern SJ. Urinary point-of-care test for smoking in the pre-operative assessment of patients undergoing elective plastic surgery. Journal of Plastic Reconstructive And Aesthetic Surgery 2006; 59: 1156-1161

• Hobbs, SD; Wilmink, ABM; Adam, DJ; et al Assessment of smoking status in patients with peripheral arterial disease. Journal of Vascular Surgery 2005; 41: 451-456

• Lawrence, T; Aveyard, P; Cheng KK, Griffin C, Johnson C, Croghan, E. Does stage-based smoking cessation advice in pregnancy result in long-term quitters? 18-month postpartum follow-up of a randomized controlled trial. Addiction 2005; 100: 107-116

• Lawrence, T; Aveyard, P; Croghan, E. What happens to women's self-reported cigarette consumption and urinary cotinine levels in pregnancy? Addiction  2003; 98: 1315-1320

• Lawrence, T; Aveyard, P; Evans O, Cheng KK. A cluster randomised controlled trial of smoking cessation in pregnant women comparing interventions based on the transtheoretical model to standard care. Tobacco Control 2003; 12: 168-177.

SmokeScreen - Urine - Independent

Cope GF

•  Cope, Graham F.; Wu, Houdini H. T.; O'Donovan, Grace V.; et al. A new point of care cotinine test for saliva to identify and monitor smoking habit. European Respiratory Journal 2012; 40: 496-497

• Sankla L, Cope GF, Chapple ILC. An evaluation of a rapid semi-quantitative saliva test for cotinine and other nicotinic metabolites to identify and monitor the use of smokeless tobacco: A pilot study. UK National Smoking Cessation Conference 2012.

• Barnfather K, Cope GF, Chapple ILC. Effect of incorporating a 10 minute point of care test for salivary nicotine metabolites into a general practice based smoking cessation programme: randomised controlled trial.  British Medical Journal 2005; 331: 999-1002

• Cope G, Nayyar P, Holder R, BrockG, Chapple I. A near-patient test for nicotine and its metabolites in saliva to assess smoking habit. Ann Clin Biochem 2000; 37: 666-673.

SmokeScreen - Saliva - Graham F. Cope

INDEPENDENT

• Spanou C, Simpson SA, Hood K, et al. Preventing disease through opportunistic, rapid engagement by primary care teams using behaviour change counselling (PRE-EMPT): protocol for a general practice-based cluster randomised trial. BMC Family Pract 2010; 11: Article No: 11

• Pascale S, Zeina A, Mirna W. Saliva cotinine and exhaled carbon monoxide in real life waterpipe smokers: a post hoc analysis. Tobacco Use Insights 2009: 2; 1–10

• Pascale S, Mirna W, Zeina A. Waterpipe smoking: Construction and validation of the Lebanon Waterpipe Dependence Scale (LWDS-11). Nicotine & Tobacco Research  2008; 10: 149-158

• Preshaw PM, Heasman L, Stacey F, et al. The effect of quitting smoking on chronic periodontitis. Journal Of Clinical Periodontology 2005; 32: 869-879

SmokeScreen - Saliva - Independent

IsoScreen - Urine - Graham F. Cope

IsoScreen - Urine - Independent

Cope GF

• Whitfield R. Cope GF. A simple urine test to monitor adherence to antituberculous drugs. Ann Clin Biochem 2004; 41: 411-413

• Cope GF, Whitfield R. Urine color testing and isoniazid monitoring. Chest 2003; 124: 2405.

INDEPENDENT

• Egere U, Sillah A, Togun T, et al.Ispniazid preventive treatment among child contacts of adults with smear-positive tuberculosis in The Gambia. Public Health Action 2016; 6(4): 226-231

• Mkopi A, Range N, Lwilla F et al. Adherence to tuberculosis therapy among patients receiving home-based directly observed treatment: evidence from the united republic of Tanzania. PLOS ONE  2012; 7: Article No: e51828

• Nicolau I, Tian L, Menzies R et al. Point-of-care urine tests for smoking status and isoniazid treatment monitoring in adult patients. PLOS One 2012; 7: Article No: e45913

• van den Boogaard J, Msoka E, Homfray M, Kibiki GS, Heldens JJHM, Felling AJA, et al. An exploration of patient perceptions of adherence to tuberculosis treatment in Tanzania. Qualitative Health Research 2012; 22:835–845

• van den Boogaard J, Lyimo, Ramsey A. Boeree, Martin J.; et al. Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study. Bulletin of The World Health Organization 2011; 89: 632-639

• Guerra RL, Conde MB, Efron A, et al. Point-of-care Arkansas method for measuring adherence to treatment with isoniazid. Respiratory Medicine 2010; 104: 754-757